MultiValent Biotherapies, Inc.
through Mar 2, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 27, 2026 · D | Mar 2, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $4,375 | — | — |
| Reported amount sold | $4,375 | $10,012,500 | $10,008,125 |
| Reported investor count | — | — | — |
| Reported minimum investment | $50 | $12,500 | $12,450 |
Earlier SEC source: 0002107846-26-000001 · Later SEC source: 0002107846-26-000002
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- —
- Reported amount sold
- $10,012,500
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0002107846-26-000002D · Mar 2, 2026 · BiotechnologySold: $10,012,500
-
0002107846-26-000001D · Feb 27, 2026 · BiotechnologyOffering: $4,375Sold: $4,375